Sharecast

{{ storiesRelated.title }}

{{ value.headline }}

Home
UK Shares
Market Data
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
Brokers
Learn on finance
Spread Bet
Economic calendar
Portfolio
Watchlist
More
Home
UK Shares
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
Funds Centre
Managers
News
Brokers
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
Learn
Strategies
Economic calendar
Portfolio
Watchlist

This website is for Private Investors* only

I am a private investor* I am not a private investor

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.

o

Remember me Forgot password?

Don’t have an account? Sign In

Tell us more

You are seeing these quotes based on previous browsing related to sectors such as

Sectors

High
Medium
Low

Banking

Energy Producers

Engineering

Mining

Categories

High
Medium
Low

Economy

Market Report

Companies

Currencies

01 Jan, 2025
Home
Market Report

PR News

20 Dec, 2024 12:19

Tabula ICAV - Net Asset Value(s)

[20.12.24]

TABULA ICAV

Fund: Janus Henderson Tabula Lux AAA CLO UCITS ETFValuation DateISIN CodeShares in IssueCurrencyShare Redeemed since Previous ValuationNET Asset ValueNAV per Share Ex Dividend Date19.12.24LU2941599081200,000.00EUR01,986,123.739.9306

Advertising

THE MOST READ

News
Market

US pre-open: Stocks set to bounce
London close: Markets end year on positive note as stocks rise
US house price growth slows in October
Haleon completes purchase of 33pc share in Chinese JV
London pre-open: Weak start expected ahead of shortened session

SEE THE FULL LIST

London open: Markets rangebound as caution sets in
London midday: Stocks drifting lower ahead of year-end
London open: FTSE nudges down in very quiet trade

SEE THE FULL LIST

SMART BOX info

More about you

High
Medium
Low

You are seeing these quotes based on previous browsing related to sectors such as:

{{ item.Description }}

You are seeing these stories as you have shown an interest in the following categories

{{ item.Description }}

Advertising

RELATED NEWS

{{ storiesRelated.scrollNewsPercent }}% Complete

Tabula ICAV - Net Asset Value(s)

US pre-open: Stocks set to bounce

Europe close: Stoxx rallies to finish 2024 on positive note

London close: Markets end year on positive note as stocks rise

dl city of london square mile financial district generic 12

Digital 9 enters deal to sell unfinished Red Sea cable project

Wizz Air inks support deal with Pratt & Whitney over aircraft groundings

Haleon completes purchase of 33pc share in Chinese JV

dl haleon plc hln health care healthcare pharmaceuticals and biotechnology pharmaceuticals ftse 100 premium 20230328 2149

Zephyr Energy receives $7.5m to fully finance well drilling and testing

dl zephyr energy aim exploration production oil gas

CleanTech reports Laguna Verde progress, revises results for ASX listing

Hummingbird refinances Coris loans with $35.6m borrowing

ValiRx further extends letter of intent with TheoremRx

About us
Advertising
Terms & Conditions
Privacy policy
Cookies
Contact

Back to the top

2025 © Sharecast.com. All rights reserved.